Abstract
Background/purpose
Hepatocellular carcinoma (HCC) during pregnancy is a very rare condition and is believed to have a worse prognosis than HCC in non-pregnant women. We evaluated the prognosis and the diagnostic and therapeutic strategies for HCC in pregnant women.
Methods
We retrospectively analyzed 4 cases in our hospital and 44 cases described in the medical literature since 1957; we also compared the cases reported before 1995 and those reported during/after 1995.
Results
The overall 6-month and 1-, 2-, and 3-year survival rates in the patients reported in the literature were 50, 29.5, 18.2, and 13.6%, respectively (n = 44). The mean ages at diagnosis before and during/after 1995 were 31.4 ± 7.2 and 28.9 ± 4.4 years, respectively (P = 0.113). The following characteristics were significantly more common in the later group: fewer pregnancies; the absence of advanced signs or symptoms; receipt of therapy; tendency to undergo surgery; and higher 6-month and 1-, 2-, and 3-year survival rates. The median survivals of the groups before and during/after 1995 were 18 and 25.5 months, respectively (P < 0.001).
Conclusions
The morbidity and mortality of HCC during pregnancy has improved over time, as diagnoses have tended to be made earlier and patients have tended to receive surgical and other treatments.
Similar content being viewed by others
References
Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907–17.
El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med. 2003;139:817–23.
Bosch FX, Ribes J, Daz M, Clries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004;127:S5–16.
Lau WY, Leung WT, Ho S, Lam SK, Li CY, Johnson PJ, et al. Hepatocellular carcinoma during pregnancy and its comparison with other pregnancy-associated malignancies. Cancer. 1995;75:2669–76.
Jeng LB, Lee WC, Wang CC, Chen MF, Hsieh TT. Hepatocellular carcinoma in a pregnant woman detected by routine screening of maternal alpha-fetoprotein. Am J Obstet Gynecol. 1995;172:219–20.
Gisi P, Floyd R. Hepatocellular carcinoma in pregnancy. A case report. J Reprod Med. 1999;44:65–7.
de la Rosa MA, Nicols-Prez D, Muiz-Montes JR, Trujillo-Carrillo JL. Evolution and management of a hepatocellular carcinoma during pregnancy. J Obstet Gynaecol Res. 2006;32:437–9.
Collier J, Sherman M. Screening for hepatocellular carcinoma. Hepatology. 1998;27:273–8.
Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol. 2001;35:421–30.
Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208–36.
Kim KS, Lee WJ, Kim BR, Cho JS, Han KH. Two cases of the hepatocellular carcinoma in pregnancy. J Korean Surg Soc. 1997;52(4):598–605.
Choi KK, Hong YJ, Choi SB, Yi NJ, Hwang S, Park YN, et al. A case of hepatocellular carcinoma in a pregnant patient in twenties. J Korean Liver Cancer Study Group. 2009;9:76–81.
Kim SI, Han SY, Yun HD, Chun EK, Sang LT, Young LJ, et al. Three cases of primary hepatocellular carcinoma first detected during pregnancy. Korean J Obstet Gynecol. 2000;43(12):2323–7.
Kim DJ, Lee SK, Oh SY, Kang YS, Kim SS, Park JJ, et al. A case of hepatocellular carcinoma associated with oral contraceptives in pregnancy. Korean J Gastroenterol. 1997;30(1):126–30.
Nam SW, Baek JT, Kang SB, Lee DS, Kim JI, Cho SH, et al. A case of the hepatocellular carcinoma during the pregnancy and metastasis to the left atrium. Korean J Hepatol. 2005;11:381–5.
Roddie TW. Haemorrhage from primary carcinoma of the liver complicating pregnancy. Br Med J. 1957;1:31.
Yen SS. Spontaneous rupture of the liver during pregnancy. A report of 2 cases. Obstet Gynecol. 1964;23:783–7.
Kim MH, Lin TJ. Silent primary carcinoma of the liver complicating pregnancy: report of a case. Obstet Gynecol. 1965;25:848–52.
Francis TI, Smith JA, Hendrickse JP. Hepatocellular carcinoma in pregnancy. East Afr Med J. 1974;51:789–800.
Purtilo DT, Clark JV, Williams R. Primary hepatic malignancy in pregnant women. Am J Obstet Gynecol. 1975;121:41–4.
Haddow JE, Thompson DK, Kloza EM. Maternal hepatoma detected during serum AFP screening. Lancet. 1980;2:806–7.
Egwuatu VE. Primary hepatocarcinoma in pregnancy. Trans R Soc Trop Med Hyg. 1980;74:793–4.
Christensen SE, Andersen VR, Vilstrup H. A case of hepatoma in pregnancy associated with earlier oral contraception. Acta Obstet Gynecol Scand. 1981;60:519.
Gonçalves CS, Pereira FE, de Vargas PR, Ferreira LS. Hepatocellular carcinoma HBsAg positive in pregnancy. Arq Gastroenterol. 1984;21:75–7.
Seaward PG, Koch MA, Mitchell RW, Merrell DA. Primary hepatocellular carcinoma in pregnancy. A case report. S Afr Med J. 1986;69:700–1.
Kroll D, Mazor M, Zirkin H, Schulman H, Glezerman M. Fibrolamellar carcinoma of the liver in pregnancy. A case report. J Reprod Med. 1991;36:823–7.
Goldberg I, Hod M, Katz I, Friedman S, Ovadia J. A case of hepatocellular carcinoma in pregnancy detected by routine screening of maternal alpha-feto-protein. Acta Obstet Gynecol Scand. 1991;70:241–2.
Nganwuchu AM, Ojo OS. Rupture of a nodule of hepatocellular carcinoma simulating uterine rupture in late pregnancy. Trop Doct. 1991;21:45–6.
Ozoh JO, Onuigbo MA, Umerah BC, Mgbor SO. Hepatoma in pregnancy. Trop Geogr Med. 1992;44:72–4.
Pajor A, Szarvas Z, Sotonyi P. Pregnancy in primary liver carcinoma. Int J Gynecol Obstet. 1992;38:235–6.
To WK, Ghosh A. Primary liver carcinoma complicating pregnancy. Aust N Z J Obstet Gynaecol. 1993;33:325–6.
Wang LR, Jeng CJ, Chu JS. Pregnancy associated with primary hepatocellular carcinoma. Obstet Gynecol. 1993;81:811–3.
Brucker C, Weiss M, Schweiberer L, Genz T, Maasen V, Debus-Thiede G. Hepatocellular carcinoma in pregnancy. Geburtshilfe Frauenheilkd. 1994;54:305–7. (in German).
Hsieh TT, Hou HC, Hsu JJ, Hsieh CC, Jeng LB. Term delivery after hepatocellular carcinoma resection in previous pregnancy. Acta Obstet Gynecol Scand. 1996;75:77–8.
Entezami M, Becker R, Ebert A, Pritze W, Weitzel H. Hepatocellular carcinoma as a rare cause of an excessive increase in alpha-fetoprotein during pregnancy. Gynecol Oncol. 1996;62:405–7.
Hsu KL, Ko SF, Cheng YF, Huang CC. Spontaneous rupture of hepatocellular carcinoma during pregnancy. Obstet Gynecol. 2001;98:913–6.
Louie-Johnsun M, Hewitt P, Perera D, Morris D. Fibrolamellar hepatocellular carcinoma in pregnancy. HPB (Oxford). 2003;5:191–3.
Ahmed A, Keeffe EB. Hypoglycemic coma in a pregnant woman in association with hepatitis B virus carrier state and hepatocellular carcinoma. J Clin Gastroenterol. 2004;38:135–6.
Cheng CH, Rivera AP, Rivera AB, Tenorio JH. Hipglicemia severa como primera manifestacion de Hepatocarcinoma en el embarazo. Rev Gastroenterol (Peru). 2005;25(2):206–9.
Imkie M, Myers SA, Li Y, Fan F, Bennett TL, Forster J, et al. Fibrolamellar hepatocellular carcinoma arising in a background of focal nodular hyperplasia: a report of 2 cases. J Reprod Med. 2005;50:633–7.
Lee HS, Han CJ, Kim CY. Predominant etiologic association of hepatitis C virus with hepatocellular carcinoma compared with hepatitis B virus in elderly patients in a hepatitis B-endemic area. Cancer. 1993;72:2564–7.
Chang P, Ong W, Lui H, Tan C. Is the prognosis of young patients with hepatocellular carcinoma poorer than the prognosis of older patients? A comparative analysis of clinical characteristics, prognostic features, and survival outcome. J Gastroenterol. 2008;43:881–8.
Sherman M. Alphafetoprotein: an obituary. J Hepatol. 2001;34:603–5.
Trevisani F, D’Intino PE, Morselli-Labate AM, Mazzella G, Accogli E, Caraceni P, et al. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol. 2001;34:570–5.
Seppl M, Ruoslahti E. Alpha fetoprotein in maternal serum: a new marker for detection of fetal distress and intrauterine death. Am J Obstet Gynecol. 1973;115:48–52.
Caballero C, Vekemans M, Lopez del Campo JG, Robyn C. Serum alpha-fetoprotein in adults, in women during pregnancy, in children at birth, and during the first week of life: a sex difference. Am J Obstet Gynecol. 1977;127:384–9.
Mizejewski GJ. Levels of alpha-fetoprotein during pregnancy and early infancy in normal and disease states. Obstet Gynecol Surv. 2003;58:804–26.
Lee HS, Chung YH, Kim CY. Specificities of serum alpha-fetoprotein in HBsAg+ and HBsAg− patients in the diagnosis of hepatocellular carcinoma. Hepatology. 1991;14:68–72.
Cobey FC, Salem R. A review of liver masses in pregnancy and a proposed algorithm for their diagnosis and management. Am J Surg. 2004;187:181–91.
Klatskin G. Hepatic tumors: possible relationship to use of oral contraceptives. Gastroenterology. 1977;73:386–94.
Heinemann LAJ, DoMinh T, Guggenmoos-Holzmann I, et al. Oral contraceptives and liver cancer. Results of the Multicentre International Liver Tumor Study (MILTS). Contraception. 1997;56:275–84.
Mucci LA, Kuper HE, Tamimi R, Lagiou P, Spanos E, Trichopoulos D. Age at menarche and age at menopause in relation to hepatocellular carcinoma in women. BJOG. 2001;108:291–4.
Hsing AW, McLaughlin JK, Hoover RN, Co Chien HT, Blot WJ, Fraumeni JF. Parity and primary liver cancer among young women. J Natl Cancer Inst. 1992;84:1118–9.
De Maria N, Manno M, Villa E. Sex hormones and liver cancer. Mol Cell Endocrinol. 2002;193:59–63.
Stanford JL, Thomas DB. Reproductive factors in the etiology of hepatocellular carcinoma. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Cancer Causes Control. 1992;3:37–42.
Acknowledgments
This study was supported by a grant of the Korea Healthcare technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A084120).
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Choi, K.K., Hong, Y.J., Choi, S.B. et al. Hepatocellular carcinoma during pregnancy: is hepatocellular carcinoma more aggressive in pregnant patients?. J Hepatobiliary Pancreat Sci 18, 422–431 (2011). https://doi.org/10.1007/s00534-010-0345-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00534-010-0345-6